NBE Therapeutics in the News

Select a year

September 17 - BioProcess International: Exelixis: Deals with NBE and Catalent bring multi-pronged ADC approach

Read more

September 9 - Pharmaceutical Business Review: Exelixis, NBE join forces for discovery and development of ADCs for cancer

Read more

September 8 - ThePharmaLetter: Exelixis and NBE-Therapeutics to work together

Read more

September 8 - pharmaphorum: Exelixis doubles down on ADCs for cancer with NBE, Catalent deals

Read more